Personalized blood thinners could slash stroke risk
NCT ID NCT06714526
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a genetic test can help doctors pick the right blood thinner for people who have had a stroke due to narrowed arteries in the brain. Some people's genes make the common drug clopidogrel less effective, so another drug, ticagrelor, may work better. The study will compare standard care with a genetic testing approach to see which is safer and more practical.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRACRANIAL ATHEROSCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dr. Mark I. Boulos - Sunnybrook Health Sciences Centre
RECRUITINGToronto, Ontario, M4N3M5, Canada
-
University of Calgary
NOT_YET_RECRUITINGCalgary, Alberta, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Cholesterol-Lowering shot reverse brain artery blockages?
- New MRI technique could help predict strokes in High-Risk patients
- New drug combo aims to stop repeat strokes in High-Risk patients
- New brain stent aims to stop strokes in High-Risk patients
- Could a diabetes drug shield your brain from stroke?
- Stenting may offer new hope for tough stroke cases